Estimated levels, modelled

What's left from your last shot?

Choose semaglutide or tirzepatide, enter your dose and frequency, and see the shape of the week — how a weekly injection rises, holds and falls before the next one.

Get the app Get the app

Get the app

Download on the App Store Get it on Google Play

Scan to install

7-day trial, no card. iPhone and Android. No ads, no data sale, ever.

  • Semaglutide
  • Tirzepatide
  • Weekly
  • Every 3.5 days
  • Titration step
The Lumara Today screen on a weekly GLP-1 protocol — the next shot due, the estimated level curve, and a weight trend.
iPhone & Android · Apple Health & Health Connect
The model

Draw the week.

Pick your compound, enter your dose and how often you take it. The curve is the shape a schedule makes — it rises after a dose, falls before the next, and stops climbing once the amount you take balances the amount you clear.

Your schedule
Labels only. The amount scales the curve; it does not change its shape, which is why the axis is a percentage.

These are shapes to draw, not schedules to adopt. Your provider sets your plan.

0%25%50%75%100%07142128354249days
35 days to settle
Percent of the settled peak, just after each dose and just before the next one.
DoseDayJust afterBefore the next
1050%26%
2775%38%
31488%45%
42194%48%
52897%50%
63598%50%
74299%51%
849100%51%
Semaglutide
35 days
until your dose once a week stops climbing — about five half-lives
Half-life
7 days
Left when the next is due
50%
Settled peak
2.0×
A simplified single-compartment model. Real absorption, distribution and individual variation differ, and a late or missed dose changes the shape entirely.
Estimated levels

A curve, not a verdict.

The chart shows relative concentration over time: it rises after a dose, falls between doses, and settles into a repeating pattern once you have been on the same step for a few weeks. It carries no clinical units and no in-range band, because neither would mean anything without a blood draw.

  • A curve built from the doses you actually logged
  • See at a glance whether you're mid-week steady or nearing your next shot
  • Titration steps show up as visible changes in the curve
The Lumara levels screen for a weekly GLP-1 — an estimated circulating-level curve across several weeks with the next dose marked.

Scan to install

7-day trial, no card. iPhone and Android.

Proof, not vibes

Then stop typing it in.

A calculator models a schedule you describe. The app charts the doses you actually took — including the one you were two days late for, which is usually the interesting one. Same model, fed by your real history instead of an assumption.

  • Weight and waist trend beside your dose history
  • Side-effect check-ins (1–5) that sit on the same timeline as each shot
  • Plain-language Insights: what changed, never what to take
Illustrative data. Insights describe what changed — they never tell you what to take.
Everything in the app

One app for the whole
of what you take.

The reminding, the logging, the remembering and the paperwork — in one place, on iPhone and Android.

Hands at a kitchen counter beside an unlabelled vial, a capped syringe and a handwritten notepad.
Lumara's Today screen: five doses today, a due-now card for Vitamin B12 with a slide-to-log control, and the week's dose history with one dose missed on Monday.

Today, and what's due

The day's doses in one list, logged with a slide, and the week behind you — taken, missed and skipped.

Lumara notification settings, with separate switches for dose reminders, refill and inventory alerts, and clinic messages.

Reminders that fire on time

A nudge at the time you set for every dose, plus refill, expiry and lab reminders. Scheduled on the phone, so they arrive with no signal.

The Lumara daily check-in, rating energy, mood, sleep quality and overall side effects on a 1–5 selector.

A daily check-in in seconds

Rate energy, mood, sleep and side effects on a 1–5 scale and tag any symptoms. Ten seconds a day is what makes a trend.

A Lumara weight entry of 181 lbs above 7-day, 30-day, 90-day and 1-year range chips and the trend line for the range shown.

Weight and symptoms, on a schedule

Log a weigh-in and how you have been feeling, with a daily or weekly reminder to do it. Both land on the same timeline as your doses.

A Lumara progress card: 130 of 154 doses taken in the last 30 days — 84% of the doses that were due — broken into taken, missed and skipped.

Progress, not just a streak

Every dose taken and missed, day by day and medicine by medicine, with your weight and check-in trends over the same weeks.

Vial tracking, circulating-level charts and the provider report are on the paid plans.

Half-life, accumulation, and why the first month feels different

Two numbers from the FDA labels shape every curve on this page. Semaglutide has a half-life of about one week, which is why it is dosed weekly and why it takes roughly four to five weeks on a given dose before the peaks and troughs stop climbing. Tirzepatide's is about five days, so it settles a little sooner. That settling is called steady state, and it is the reason the third week on a new step often feels different from the first.

What the curve cannot tell you

  • It is not a blood level and carries no clinical units.
  • It cannot account for how your body absorbs, distributes or clears the compound.
  • It says nothing about whether a dose is right, safe or working for you.
  • It is not a reason to change anything about your protocol.

A model, not a measurement. This is an approximation from your own dose history — it is not a blood test, carries no clinical units, and is never a recommendation. Only your provider can interpret your actual levels.

Sources

Product information as of 5 September 2026.

Questions

Good to know.

Semaglutide's published half-life is about one week, and the FDA label notes it takes roughly five weeks after a final dose for it to clear. That is also why a change in dose takes about a month to fully settle.

About five days, per the FDA label — shorter than semaglutide, which is why its curve dips a little more between weekly doses and reaches a steady pattern slightly sooner.

Roughly four to five weeks on the same dose for semaglutide and around four for tirzepatide. Every dose step restarts that clock, which is why the labels space the steps about four weeks apart.

No, and no app can. This is a model built from a published half-life and the schedule you type in. It carries no clinical units and is never a recommendation. Only a blood test ordered and read by your provider measures anything.

The shape is set by the half-life and how often you dose — that is what the chart shows. The amount scales it. The curve is relative on purpose: an absolute number would imply a precision this model does not have.

Your data is encrypted on your device, backups are encrypted, and we never sell data or show ads. Export or delete everything from inside the app.

No. Lumara is a tracking and education tool. It doesn't prescribe, diagnose, or replace your provider's guidance.

Stop guessing.
Start seeing.

Set up your GLP-1 in about two minutes. 7-day trial, iPhone and Android, no ads — ever.

Scan to install

Free to download. No ads, no data sale, ever.

Lumara is a tracking and education tool. It is not a medical device and does not provide medical advice, diagnosis, or treatment. Always follow your provider's instructions.